Interleukin-33 as a central immune modulator of glymphatic dysfunction in Alzheimers disease - toward a unified immune-fluidic framework

For citation: Abdel-Sater Kh.A. Interleukin-33 as a central immune modulator of glymphatic dysfunction in Alzheimer’s disease: toward a unified immune-fluidic framework. Clinical review for general practice. 2026; 7 (8): 47–51. DOI: 10.47407/kr2026.7.8.00899

All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.